Merit Medical Systems Inc MMSI
We take great care to ensure that the data presented and summarized in this overview for MERIT MEDICAL SYSTEMS INC is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding MMSI
View all-
Black Rock Inc. New York, NY8.91MShares$933 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.59MShares$690 Million0.01% of portfolio
-
Conestoga Capital Advisors, LLC2.29MShares$240 Million3.13% of portfolio
-
State Street Corp Boston, MA2.23MShares$234 Million0.01% of portfolio
-
Fuller & Thaler Asset Management, Inc. San Mateo, CA1.6MShares$167 Million0.63% of portfolio
-
Macquarie Group LTD Australia, C31.59MShares$166 Million0.17% of portfolio
-
Arrow Mark Colorado Holdings LLC Denver, CO1.46MShares$152 Million2.04% of portfolio
-
William Blair Investment Management, LLC Chicago, IL1.44MShares$151 Million0.36% of portfolio
-
Invesco Ltd. Atlanta, GA1.42MShares$148 Million0.03% of portfolio
-
Geode Capital Management, LLC Boston, MA1.36MShares$142 Million0.01% of portfolio
Latest Institutional Activity in MMSI
Top Purchases
Top Sells
About MMSI
Merit Medical Systems, Inc. designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures, primarily in cardiology, radiology, oncology, critical care, and endoscopy. The company operates in two segments, Cardiovascular and Endoscopy. It provides peripheral intervention products for the diagnosis and treatment of diseases in peripheral vessels and organs; and cardiac intervention products, such as access, angiography, electrophysiology and cardiac rhythm management, fluid management, hemodynamic monitoring, hemostasis, and intervention to treat various heart conditions. The company also offers custom procedural solutions that include critical care products, disinfection protection systems, syringes, manifold kits, and trays and packs; coated tubes and wires; and sensor components for microelectromechanical systems. In addition, it provides pulmonary products that consist of laser-cut tracheobronchial stents, over-the-wire and direct visualization delivery systems, and dilation balloons to endoscopically dilate strictures; gastroenterology products; and kits and accessories for endoscopy and bronchoscopy procedures. The company sells its products to hospitals and alternate site-based physicians, technicians, and nurses through direct sales force, distributors, original equipment manufacturer partners, or custom procedure tray manufacturers in the United States and internationally. Merit Medical Systems, Inc. was incorporated in 1987 and is headquartered in South Jordan, Utah.
Insider Transactions at MMSI
Insider Transaction List
View allDate | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Nov 15
2024
|
F. Ann Millner |
SELL
Open market or private sale
|
Direct |
12,500
-27.85%
|
$1,262,500
$101.55 P/Share
|
Nov 15
2024
|
F. Ann Millner |
BUY
Exercise of conversion of derivative security
|
Direct |
12,500
+21.78%
|
$625,000
$50.5 P/Share
|
Nov 07
2024
|
Raul Parra Jr. CFO AND TREASURER |
SELL
Open market or private sale
|
Direct |
5,361
-24.68%
|
$546,822
$102.18 P/Share
|
Nov 07
2024
|
Raul Parra Jr. CFO AND TREASURER |
BUY
Exercise of conversion of derivative security
|
Direct |
5,361
+19.79%
|
$198,357
$37.71 P/Share
|
Nov 05
2024
|
Raul Parra Jr. CFO AND TREASURER |
SELL
Open market or private sale
|
Direct |
29,646
-64.44%
|
$2,905,308
$98.02 P/Share
|
Nov 05
2024
|
Raul Parra Jr. CFO AND TREASURER |
BUY
Exercise of conversion of derivative security
|
Direct |
34,000
+29.73%
|
$1,700,000
$50.26 P/Share
|
Nov 05
2024
|
Neil Peterson CHIEF OPERATING OFFICER |
SELL
Open market or private sale
|
Direct |
5,000
-25.23%
|
$490,000
$98.0 P/Share
|
Nov 05
2024
|
Neil Peterson CHIEF OPERATING OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+20.15%
|
$270,000
$54.4 P/Share
|
Jun 28
2024
|
F. Ann Millner |
SELL
Open market or private sale
|
Direct |
12,500
-14.01%
|
$1,062,500
$85.0 P/Share
|
Jun 28
2024
|
F. Ann Millner |
BUY
Exercise of conversion of derivative security
|
Direct |
12,500
+21.78%
|
$625,000
$50.5 P/Share
|
Jun 10
2024
|
Neil Peterson CHIEF OPERATING OFFICER |
SELL
Open market or private sale
|
Direct |
7,500
-33.6%
|
$607,500
$81.85 P/Share
|
Jun 10
2024
|
Neil Peterson CHIEF OPERATING OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
7,500
+25.15%
|
$330,000
$44.8 P/Share
|
May 16
2024
|
Thomas James Gunderson |
BUY
Grant, award, or other acquisition
|
Direct |
2,431
+10.08%
|
-
|
May 16
2024
|
Lonny J Carpenter |
BUY
Grant, award, or other acquisition
|
Direct |
2,431
+13.78%
|
-
|
May 16
2024
|
Stephen C. Evans |
BUY
Grant, award, or other acquisition
|
Direct |
2,431
+20.11%
|
-
|
May 16
2024
|
Michael R Mcdonnell |
BUY
Grant, award, or other acquisition
|
Direct |
2,431
+23.89%
|
-
|
May 16
2024
|
Lynne Ward |
BUY
Grant, award, or other acquisition
|
Direct |
2,431
+18.57%
|
-
|
May 16
2024
|
Silvia Perez |
BUY
Grant, award, or other acquisition
|
Direct |
2,431
+50.0%
|
-
|
May 16
2024
|
F. Ann Millner |
BUY
Grant, award, or other acquisition
|
Direct |
2,431
+6.98%
|
-
|
May 16
2024
|
David Floyd |
BUY
Grant, award, or other acquisition
|
Direct |
2,431
+21.49%
|
-
|
Last 12 Months Summary
Grant, award, or other acquisition | 128K shares |
---|---|
Exercise of conversion of derivative security | 154K shares |
Open market or private sale | 143K shares |
---|---|
Payment of exercise price or tax liability | 20.8K shares |
Bona fide gift | 1.5K shares |